📰 Bio Path News
Page 4 - Bio Path News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Path. Real-time updates on events, politics, business and more.
July 13, 2023
Research analysts at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the stock. Separately, Roth Capital reiterated a “buy” rating on shares of Bio-Path in a research note on Friday, March 17th. Bio-Path Price Performance NASDAQ BPTH opened […]
June 13, 2023
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note released on Friday. The firm issued a sell rating on the stock. Separately, Roth Capital restated a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Stock Up 4.4 % Shares of NASDAQ BPTH […]
June 5, 2023
Bio-Path (NASDAQ:BPTH – Get Rating) and RVL Pharmaceuticals (NASDAQ:RVLP – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Profitability This table compares Bio-Path and RVL Pharmaceuticals’ net margins, […]
June 3, 2023
Equities researchers at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report issued on Thursday. The firm set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Performance Shares of NASDAQ:BPTH opened […]
May 31, 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 74,700 shares, a growth of 6.1% from the April 30th total of 70,400 shares. Based on an average daily volume of 29,600 shares, the short-interest ratio is […]
May 26, 2023
Investment analysts at StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Roth Capital reaffirmed a “buy” rating on shares of Bio-Path in a research note on Friday, March 17th. Bio-Path Stock Performance NASDAQ BPTH […]
May 20, 2023
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report report published on Tuesday morning. The brokerage issued a sell rating on the stock. Separately, Roth Capital reissued a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Trading Up 2.7 % Shares of […]
May 16, 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) saw a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 70,400 shares, a decline of 15.8% from the April 15th total of 83,600 shares. Based on an average trading volume of 31,100 shares, the days-to-cover ratio is […]
May 16, 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) saw a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 70,400 shares, a drop of 15.8% from the April 15th total of 83,600 shares. Based on an average daily trading volume, of 31,100 shares, the short-interest ratio […]
May 12, 2023
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a report released on Monday morning. The brokerage issued a sell rating on the stock. Separately, Roth Capital restated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Up 0.6 % BPTH opened at $1.52 on […]